Gabrielle Zuckerman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Gabrielle Zuckerman has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Sherine El-Toukhy
Division of Intramural Research, National Institute on Minority Health and Health Disparities, National Institutes of Health, Rockville, Maryland
5 shared publications - Phillip Hegeman
NIMHD, Div Intramural Res, NIH, 11545 Rockville Pike, Rockville, MD 20852 USA
4 shared publications - Anirban Roy Das
Biostrap USA LLC, Lakeway, TX USA
2 shared publications - James F. Troendle
Office of Biostatistics Research Division of Intramural Research of the National Heart, Lung, and Blood Institute, NIH/DHHS Bethesda Maryland USA
2 shared publications - James Russell Pike
Optimal Aging Institute New York University Grossman School of Medicine New York New York USA
2 shared publications - Nia Moses
NIMHD, Div Intramural Res, NIH, 11545 Rockville Pike, Rockville, MD 20852 USA
2 shared publications
Latest Publications
- Open Access
- 17 November 2026
- Published by Springer Nature in Journal of Urban Health
The Neighborhood-Level Association Between Renter Cost Burden and Fatal Opioid-Involved Overdoses, Chicago, IL, 2015-2023
Housing insecurity, including homelessness and eviction, is linked to higher fatal overdose risk. However, the relationship between renter cost burden and fatal opioid-involved overdose remains unclear. This study examined the neighborhood-level association between renter cost burden and fatal opioid-involved overdoses across time in an urban setting. We conducted a cross-sectional analysis of Chicago census tracts using locations of opioid-involved fatal overdoses from the Cook County Medical Examiner’s Office, 2015–2023 ( n = 8423). Renter cost burden, defined as the percentage of renter households spending ≥ 30% of income on housing, was obtained for Chicago census tracts from the American Community Survey. We used negative binomial regression to estimate the association between renter cost burden and severe cost burden (≥ 50%) and fatal overdose rate by year, controlling for neighborhood variables (e.g., income, segregation, and population density). We observed positive spatial autocorrelation, indicating spatial clustering of census tracts with a high proportion of cost-burdened renters and fatal overdose rates. We found consistent positive associations between fatal overdose rates and renter cost burden and severe cost burden over time, controlling for neighborhood demographics. For example, in 2023, each 10-percentage point higher proportion of cost-burdened renters was associated with a 9% higher fatal overdose rate (aIRR = 1.09, 95% CI [1.02, 1.17]). These findings support further investigation of the relationship between renter cost burden and fatal overdose and motivate studies using quasi-experimental designs to assess whether upstream housing interventions (e.g., rental assistance) may reduce fatal overdose risk.
- 17 November 2026
- Published by Springer Nature in Journal of Urban Health
Open AccessThe Neighborhood-Level Association Between Renter Cost Burden and Fatal Opioid-Involved Overdoses, Chicago, IL, 2015-2023
Housing insecurity, including homelessness and eviction, is linked to higher fatal overdose risk. However, the relationship between renter cost burden and fatal opioid-involved overdose remains unclear. This study examined the neighborhood-level association between renter cost burden and fatal opioid-involved overdoses across time in an urban setting. We conducted a cross-sectional analysis of Chicago census tracts using locations of opioid-involved fatal overdoses from the Cook County Medical Examiner’s Office, 2015–2023 ( n = 8423). Renter cost burden, defined as the percentage of renter households spending ≥ 30% of income on housing, was obtained for Chicago census tracts from the American Community Survey. We used negative binomial regression to estimate the association between renter cost burden and severe cost burden (≥ 50%) and fatal overdose rate by year, controlling for neighborhood variables (e.g., income, segregation, and population density). We observed positive spatial autocorrelation, indicating spatial clustering of census tracts with a high proportion of cost-burdened renters and fatal overdose rates. We found consistent positive associations between fatal overdose rates and renter cost burden and severe cost burden over time, controlling for neighborhood demographics. For example, in 2023, each 10-percentage point higher proportion of cost-burdened renters was associated with a 9% higher fatal overdose rate (aIRR = 1.09, 95% CI [1.02, 1.17]). These findings support further investigation of the relationship between renter cost burden and fatal overdose and motivate studies using quasi-experimental designs to assess whether upstream housing interventions (e.g., rental assistance) may reduce fatal overdose risk.
- Open Access
- 16 August 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13 (1) , e57382
Study of Postacute Sequelae of COVID-19 Using Digital Wearables: Protocol for a Prospective Longitudinal Observational Study
Background: Postacute sequelae of COVID-19 (PASC) remain understudied in nonhospitalized patients. Digital wearables allow for a continuous collection of physiological parameters such as respiratory rate and oxygen saturation that have been predictive of disease trajectories in hospitalized patients. Objective: This protocol outlines the design and procedures of a prospective, longitudinal, observational study of PASC that aims to identify wearables-collected physiological parameters that are associated with PASC in patients with a positive diagnosis. Methods: This is a single-arm, prospective, observational study of a cohort of 550 patients, aged 18 to 65 years, male or female, who own a smartphone or a tablet that meets predetermined Bluetooth version and operating system requirements, speak English, and provide documentation of a positive COVID-19 test issued by a health care professional within 5 days before enrollment. The primary end point is long COVID-19, defined as ≥1 symptom at 3 weeks beyond the first symptom onset or positive diagnosis, whichever comes first. The secondary end point is chronic COVID-19, defined as ≥1 symptom at 12 weeks beyond the first symptom onset or positive diagnosis. Participants must be willing and able to consent to participate in the study and adhere to study procedures for 6 months. Results: The first patient was enrolled in October 2021. The estimated year for publishing the study results is 2025. Conclusions: This is a fully decentralized study investigating PASC using wearable devices to collect physiological parameters and patient-reported outcomes. The study will shed light on the duration and symptom manifestation of PASC in nonhospitalized patient subgroups and is an exemplar of the use of wearables as population-level monitoring health tools for communicable diseases. Trial Registration: ClinicalTrials.gov NCT04927442; https://clinicaltrials.gov/study/NCT04927442 International Registered Report Identifier (IRRID): DERR1-10.2196/57382
- 16 August 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13 (1) , e57382
Open AccessStudy of Postacute Sequelae of COVID-19 Using Digital Wearables: Protocol for a Prospective Longitudinal Observational Study
Background: Postacute sequelae of COVID-19 (PASC) remain understudied in nonhospitalized patients. Digital wearables allow for a continuous collection of physiological parameters such as respiratory rate and oxygen saturation that have been predictive of disease trajectories in hospitalized patients. Objective: This protocol outlines the design and procedures of a prospective, longitudinal, observational study of PASC that aims to identify wearables-collected physiological parameters that are associated with PASC in patients with a positive diagnosis. Methods: This is a single-arm, prospective, observational study of a cohort of 550 patients, aged 18 to 65 years, male or female, who own a smartphone or a tablet that meets predetermined Bluetooth version and operating system requirements, speak English, and provide documentation of a positive COVID-19 test issued by a health care professional within 5 days before enrollment. The primary end point is long COVID-19, defined as ≥1 symptom at 3 weeks beyond the first symptom onset or positive diagnosis, whichever comes first. The secondary end point is chronic COVID-19, defined as ≥1 symptom at 12 weeks beyond the first symptom onset or positive diagnosis. Participants must be willing and able to consent to participate in the study and adhere to study procedures for 6 months. Results: The first patient was enrolled in October 2021. The estimated year for publishing the study results is 2025. Conclusions: This is a fully decentralized study investigating PASC using wearable devices to collect physiological parameters and patient-reported outcomes. The study will shed light on the duration and symptom manifestation of PASC in nonhospitalized patient subgroups and is an exemplar of the use of wearables as population-level monitoring health tools for communicable diseases. Trial Registration: ClinicalTrials.gov NCT04927442; https://clinicaltrials.gov/study/NCT04927442 International Registered Report Identifier (IRRID): DERR1-10.2196/57382
- Open Access
- 15 February 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Study of Postacute Sequelae of COVID-19 Using Digital Wearables: Protocol for a Prospective Longitudinal Observational Study (Preprint)
BACKGROUND Postacute sequelae of COVID-19 (PASC) remain understudied in nonhospitalized patients. Digital wearables allow for a continuous collection of physiological parameters such as respiratory rate and oxygen saturation that have been predictive of disease trajectories in hospitalized patients. OBJECTIVE This protocol outlines the design and procedures of a prospective, longitudinal, observational study of PASC that aims to identify wearables-collected physiological parameters that are associated with PASC in patients with a positive diagnosis. METHODS This is a single-arm, prospective, observational study of a cohort of 550 patients, aged 18 to 65 years, male or female, who own a smartphone or a tablet that meets predetermined Bluetooth version and operating system requirements, speak English, and provide documentation of a positive COVID-19 test issued by a health care professional within 5 days before enrollment. The primary end point is long COVID-19, defined as ≥1 symptom at 3 weeks beyond the first symptom onset or positive diagnosis, whichever comes first. The secondary end point is chronic COVID-19, defined as ≥1 symptom at 12 weeks beyond the first symptom onset or positive diagnosis. Participants must be willing and able to consent to participate in the study and adhere to study procedures for 6 months. RESULTS The first patient was enrolled in October 2021. The estimated year for publishing the study results is 2025. CONCLUSIONS This is a fully decentralized study investigating PASC using wearable devices to collect physiological parameters and patient-reported outcomes. The study will shed light on the duration and symptom manifestation of PASC in nonhospitalized patient subgroups and is an exemplar of the use of wearables as population-level monitoring health tools for communicable diseases. CLINICALTRIAL ClinicalTrials.gov NCT04927442; https://clinicaltrials.gov/study/NCT04927442 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/57382
- 15 February 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessStudy of Postacute Sequelae of COVID-19 Using Digital Wearables: Protocol for a Prospective Longitudinal Observational Study (Preprint)
BACKGROUND Postacute sequelae of COVID-19 (PASC) remain understudied in nonhospitalized patients. Digital wearables allow for a continuous collection of physiological parameters such as respiratory rate and oxygen saturation that have been predictive of disease trajectories in hospitalized patients. OBJECTIVE This protocol outlines the design and procedures of a prospective, longitudinal, observational study of PASC that aims to identify wearables-collected physiological parameters that are associated with PASC in patients with a positive diagnosis. METHODS This is a single-arm, prospective, observational study of a cohort of 550 patients, aged 18 to 65 years, male or female, who own a smartphone or a tablet that meets predetermined Bluetooth version and operating system requirements, speak English, and provide documentation of a positive COVID-19 test issued by a health care professional within 5 days before enrollment. The primary end point is long COVID-19, defined as ≥1 symptom at 3 weeks beyond the first symptom onset or positive diagnosis, whichever comes first. The secondary end point is chronic COVID-19, defined as ≥1 symptom at 12 weeks beyond the first symptom onset or positive diagnosis. Participants must be willing and able to consent to participate in the study and adhere to study procedures for 6 months. RESULTS The first patient was enrolled in October 2021. The estimated year for publishing the study results is 2025. CONCLUSIONS This is a fully decentralized study investigating PASC using wearable devices to collect physiological parameters and patient-reported outcomes. The study will shed light on the duration and symptom manifestation of PASC in nonhospitalized patient subgroups and is an exemplar of the use of wearables as population-level monitoring health tools for communicable diseases. CLINICALTRIAL ClinicalTrials.gov NCT04927442; https://clinicaltrials.gov/study/NCT04927442 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/57382
- 15 December 2023
- Published by Elsevier in Journal of Adolescent Health
- Vol. 74 (3) , 466-478
Noncigarette Tobacco Product Use Among Smoking-Susceptible and Nonsusceptible Adolescent Never Smokers, 2009–2021
- 15 December 2023
- Published by Elsevier in Journal of Adolescent Health
- Vol. 74 (3) , 466-478
Noncigarette Tobacco Product Use Among Smoking-Susceptible and Nonsusceptible Adolescent Never Smokers, 2009–2021
- Open Access
- 25 September 2023
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 12 (1) , e47567
Decision Trade-Offs in Ecological Momentary Assessments and Digital Wearables Uptake: Protocol for a Discrete Choice Experiment
Background: Ecological momentary assessments (EMAs) and digital wearables (DW) are commonly used remote monitoring technologies that capture real-time data in people’s natural environments. Real-time data are core to personalized medical care and intensively adaptive health interventions. The utility of such personalized care is contingent on user uptake and continued use of EMA and DW. Consequently, it is critical to understand user preferences that may increase the uptake of EMA and DW. Objective: The study aims to quantify users’ preferences of EMA and DW, examine variations in users’ preferences across demographic and behavioral subgroups, and assess the association between users’ preferences and intentions to use EMA and DW. Methods: We will administer 2 discrete choice experiments (DCEs) paired with self-report surveys on the internet to a total of 3260 US adults through Qualtrics. The first DCE will assess participants’ EMA preferences using a choice-based conjoint design that will ask participants to compare the relative importance of prompt frequency, number of questions per prompt, prompt type, health topic, and assessment duration. The second DCE will measure participants’ DW preferences using a maximum difference scaling design that will quantify the relative importance of device characteristics, effort expectancy, social influence, and facilitating technical, health care, and market factors. Hierarchical Bayesian multinomial logistic regression models will be used to generate subject-specific preference utilities. Preference utilities will be compared across demographic (ie, sex, age, race, and ethnicity) and behavioral (ie, substance use, physical activity, dietary behavior, and sleep duration) subgroups. Regression models will determine whether specific utilities are associated with attitudes toward or intentions to use EMA and DW. Mixture models will determine the associations of attitudes toward and intentions to use EMA and DW with latent profiles of user preferences. Results: The institutional review board approved the study on December 19, 2022. Data collection started on January 20, 2023, and concluded on May 4, 2023. Data analysis is currently underway. Conclusions: The study will provide evidence on users’ preferences of EMA and DW features that can improve initial uptake and potentially continued use of these remote monitoring tools. The sample size and composition allow for subgroup analysis by demographics and health behaviors and will provide evidence on associations between users’ preferences and intentions to uptake EMA and DW. Limitations include the cross-sectional nature of the study, which limits our ability to measure direct behavior. Rather, we capture behavioral intentions for EMA and DW uptake. The nonprobability sample limits the generalizability of the results and introduces self-selection bias related to the demographic and behavioral characteristics of participants who belong to web-based survey panels. International Registered Report Identifier (IRRID): DERR1-10.2196/47567
- 25 September 2023
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 12 (1) , e47567
Open AccessDecision Trade-Offs in Ecological Momentary Assessments and Digital Wearables Uptake: Protocol for a Discrete Choice Experiment
Background: Ecological momentary assessments (EMAs) and digital wearables (DW) are commonly used remote monitoring technologies that capture real-time data in people’s natural environments. Real-time data are core to personalized medical care and intensively adaptive health interventions. The utility of such personalized care is contingent on user uptake and continued use of EMA and DW. Consequently, it is critical to understand user preferences that may increase the uptake of EMA and DW. Objective: The study aims to quantify users’ preferences of EMA and DW, examine variations in users’ preferences across demographic and behavioral subgroups, and assess the association between users’ preferences and intentions to use EMA and DW. Methods: We will administer 2 discrete choice experiments (DCEs) paired with self-report surveys on the internet to a total of 3260 US adults through Qualtrics. The first DCE will assess participants’ EMA preferences using a choice-based conjoint design that will ask participants to compare the relative importance of prompt frequency, number of questions per prompt, prompt type, health topic, and assessment duration. The second DCE will measure participants’ DW preferences using a maximum difference scaling design that will quantify the relative importance of device characteristics, effort expectancy, social influence, and facilitating technical, health care, and market factors. Hierarchical Bayesian multinomial logistic regression models will be used to generate subject-specific preference utilities. Preference utilities will be compared across demographic (ie, sex, age, race, and ethnicity) and behavioral (ie, substance use, physical activity, dietary behavior, and sleep duration) subgroups. Regression models will determine whether specific utilities are associated with attitudes toward or intentions to use EMA and DW. Mixture models will determine the associations of attitudes toward and intentions to use EMA and DW with latent profiles of user preferences. Results: The institutional review board approved the study on December 19, 2022. Data collection started on January 20, 2023, and concluded on May 4, 2023. Data analysis is currently underway. Conclusions: The study will provide evidence on users’ preferences of EMA and DW features that can improve initial uptake and potentially continued use of these remote monitoring tools. The sample size and composition allow for subgroup analysis by demographics and health behaviors and will provide evidence on associations between users’ preferences and intentions to uptake EMA and DW. Limitations include the cross-sectional nature of the study, which limits our ability to measure direct behavior. Rather, we capture behavioral intentions for EMA and DW uptake. The nonprobability sample limits the generalizability of the results and introduces self-selection bias related to the demographic and behavioral characteristics of participants who belong to web-based survey panels. International Registered Report Identifier (IRRID): DERR1-10.2196/47567
- Open Access
- 24 March 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Decision Trade-Offs in Ecological Momentary Assessments and Digital Wearables Uptake: Protocol for a Discrete Choice Experiment (Preprint)
BACKGROUND Ecological momentary assessments (EMAs) and digital wearables (DW) are commonly used remote monitoring technologies that capture real-time data in people’s natural environments. Real-time data are core to personalized medical care and intensively adaptive health interventions. The utility of such personalized care is contingent on user uptake and continued use of EMA and DW. Consequently, it is critical to understand user preferences that may increase the uptake of EMA and DW. OBJECTIVE The study aims to quantify users’ preferences of EMA and DW, examine variations in users’ preferences across demographic and behavioral subgroups, and assess the association between users’ preferences and intentions to use EMA and DW. METHODS We will administer 2 discrete choice experiments (DCEs) paired with self-report surveys on the internet to a total of 3260 US adults through Qualtrics. The first DCE will assess participants’ EMA preferences using a choice-based conjoint design that will ask participants to compare the relative importance of prompt frequency, number of questions per prompt, prompt type, health topic, and assessment duration. The second DCE will measure participants’ DW preferences using a maximum difference scaling design that will quantify the relative importance of device characteristics, effort expectancy, social influence, and facilitating technical, health care, and market factors. Hierarchical Bayesian multinomial logistic regression models will be used to generate subject-specific preference utilities. Preference utilities will be compared across demographic (ie, sex, age, race, and ethnicity) and behavioral (ie, substance use, physical activity, dietary behavior, and sleep duration) subgroups. Regression models will determine whether specific utilities are associated with attitudes toward or intentions to use EMA and DW. Mixture models will determine the associations of attitudes toward and intentions to use EMA and DW with latent profiles of user preferences. RESULTS The institutional review board approved the study on December 19, 2022. Data collection started on January 20, 2023, and concluded on May 4, 2023. Data analysis is currently underway. CONCLUSIONS The study will provide evidence on users’ preferences of EMA and DW features that can improve initial uptake and potentially continued use of these remote monitoring tools. The sample size and composition allow for subgroup analysis by demographics and health behaviors and will provide evidence on associations between users’ preferences and intentions to uptake EMA and DW. Limitations include the cross-sectional nature of the study, which limits our ability to measure direct behavior. Rather, we capture behavioral intentions for EMA and DW uptake. The nonprobability sample limits the generalizability of the results and introduces self-selection bias related to the demographic and behavioral characteristics of participants who belong to web-based survey panels. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/47567
- 24 March 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDecision Trade-Offs in Ecological Momentary Assessments and Digital Wearables Uptake: Protocol for a Discrete Choice Experiment (Preprint)
BACKGROUND Ecological momentary assessments (EMAs) and digital wearables (DW) are commonly used remote monitoring technologies that capture real-time data in people’s natural environments. Real-time data are core to personalized medical care and intensively adaptive health interventions. The utility of such personalized care is contingent on user uptake and continued use of EMA and DW. Consequently, it is critical to understand user preferences that may increase the uptake of EMA and DW. OBJECTIVE The study aims to quantify users’ preferences of EMA and DW, examine variations in users’ preferences across demographic and behavioral subgroups, and assess the association between users’ preferences and intentions to use EMA and DW. METHODS We will administer 2 discrete choice experiments (DCEs) paired with self-report surveys on the internet to a total of 3260 US adults through Qualtrics. The first DCE will assess participants’ EMA preferences using a choice-based conjoint design that will ask participants to compare the relative importance of prompt frequency, number of questions per prompt, prompt type, health topic, and assessment duration. The second DCE will measure participants’ DW preferences using a maximum difference scaling design that will quantify the relative importance of device characteristics, effort expectancy, social influence, and facilitating technical, health care, and market factors. Hierarchical Bayesian multinomial logistic regression models will be used to generate subject-specific preference utilities. Preference utilities will be compared across demographic (ie, sex, age, race, and ethnicity) and behavioral (ie, substance use, physical activity, dietary behavior, and sleep duration) subgroups. Regression models will determine whether specific utilities are associated with attitudes toward or intentions to use EMA and DW. Mixture models will determine the associations of attitudes toward and intentions to use EMA and DW with latent profiles of user preferences. RESULTS The institutional review board approved the study on December 19, 2022. Data collection started on January 20, 2023, and concluded on May 4, 2023. Data analysis is currently underway. CONCLUSIONS The study will provide evidence on users’ preferences of EMA and DW features that can improve initial uptake and potentially continued use of these remote monitoring tools. The sample size and composition allow for subgroup analysis by demographics and health behaviors and will provide evidence on associations between users’ preferences and intentions to uptake EMA and DW. Limitations include the cross-sectional nature of the study, which limits our ability to measure direct behavior. Rather, we capture behavioral intentions for EMA and DW uptake. The nonprobability sample limits the generalizability of the results and introduces self-selection bias related to the demographic and behavioral characteristics of participants who belong to web-based survey panels. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/47567